Publication Information

{'id': 'https://openalex.org/W2380964687', 'doi': None, 'title': 'Clinical development of tyrosine kinase inhibitors targeted platelet-derived growth factor receptor', 'display_name': 'Clinical development of tyrosine kinase inhibitors targeted platelet-derived growth factor receptor', 'publication_year': 2006, 'publication_date': '2006-01-01', 'ids': {'openalex': 'https://openalex.org/W2380964687', 'mag': '2380964687'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-XYYL200606017.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764853906', 'display_name': 'Chinese Journal of New Drugs and Clinical Remedies', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4323986928', 'host_organization_name': 'Zhongguo Yao Xuehui Shanghai Fenhui', 'host_organization_lineage': ['https://openalex.org/P4323986928'], 'host_organization_lineage_names': ['Zhongguo Yao Xuehui Shanghai Fenhui'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5089348951', 'display_name': 'Jian Ding', 'orcid': 'https://orcid.org/0000-0002-5815-4956'}, 'institutions': [{'id': 'https://openalex.org/I4210112820', 'display_name': 'Shanghai Institute of Materia Medica', 'ror': 'https://ror.org/022syn853', 'country_code': 'CN', 'type': 'facility', 'lineage': ['https://openalex.org/I19820366', 'https://openalex.org/I4210112820']}, {'id': 'https://openalex.org/I19820366', 'display_name': 'Chinese Academy of Sciences', 'ror': 'https://ror.org/034t30j35', 'country_code': 'CN', 'type': 'government', 'lineage': ['https://openalex.org/I19820366']}], 'countries': ['CN'], 'is_corresponding': True, 'raw_author_name': 'Ding Jian', 'raw_affiliation_strings': ['Division of Anti-tumor Pharmacology,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Shanghai Institutes for Biological Science,Chinese Academy of Sciences,SHANGHAI 201203,China)'], 'affiliations': [{'raw_affiliation_string': 'Division of Anti-tumor Pharmacology,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Shanghai Institutes for Biological Science,Chinese Academy of Sciences,SHANGHAI 201203,China)', 'institution_ids': ['https://openalex.org/I4210112820', 'https://openalex.org/I19820366']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5089348951'], 'corresponding_institution_ids': ['https://openalex.org/I4210112820', 'https://openalex.org/I19820366'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 61}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12318', 'display_name': 'Quinazolinone synthesis and applications', 'score': 0.9645, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12318', 'display_name': 'Quinazolinone synthesis and applications', 'score': 0.9645, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T10422', 'display_name': 'Angiogenesis and VEGF in Cancer', 'score': 0.9615, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9487, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/platelet-derived-growth-factor', 'display_name': 'Platelet-derived growth factor', 'score': 0.685575}], 'concepts': [{'id': 'https://openalex.org/C180361614', 'wikidata': 'https://www.wikidata.org/wiki/Q7202242', 'display_name': 'Platelet-derived growth factor receptor', 'level': 4, 'score': 0.8908669}, {'id': 'https://openalex.org/C2781294074', 'wikidata': 'https://www.wikidata.org/wiki/Q22327352', 'display_name': 'Platelet-derived growth factor', 'level': 5, 'score': 0.685575}, {'id': 'https://openalex.org/C101544691', 'wikidata': 'https://www.wikidata.org/wiki/Q420511', 'display_name': 'Receptor tyrosine kinase', 'level': 3, 'score': 0.59737027}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5635598}, {'id': 'https://openalex.org/C42362537', 'wikidata': 'https://www.wikidata.org/wiki/Q87099740', 'display_name': 'Tyrosine kinase', 'level': 3, 'score': 0.5617964}, {'id': 'https://openalex.org/C62478195', 'wikidata': 'https://www.wikidata.org/wiki/Q828130', 'display_name': 'Signal transduction', 'level': 2, 'score': 0.5496302}, {'id': 'https://openalex.org/C26375932', 'wikidata': 'https://www.wikidata.org/wiki/Q118226', 'display_name': 'Growth factor receptor', 'level': 3, 'score': 0.54211485}, {'id': 'https://openalex.org/C2775960820', 'wikidata': 'https://www.wikidata.org/wiki/Q408378', 'display_name': 'Growth factor', 'level': 3, 'score': 0.5346405}, {'id': 'https://openalex.org/C2778820342', 'wikidata': 'https://www.wikidata.org/wiki/Q906415', 'display_name': 'Tyrosine-kinase inhibitor', 'level': 3, 'score': 0.4891639}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.46427128}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.38243714}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.38169053}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.33472216}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.30030614}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.2092624}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.20431864}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-XYYL200606017.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764853906', 'display_name': 'Chinese Journal of New Drugs and Clinical Remedies', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4323986928', 'host_organization_name': 'Zhongguo Yao Xuehui Shanghai Fenhui', 'host_organization_lineage': ['https://openalex.org/P4323986928'], 'host_organization_lineage_names': ['Zhongguo Yao Xuehui Shanghai Fenhui'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.53}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3036512713', 'https://openalex.org/W2803340083', 'https://openalex.org/W2370561079', 'https://openalex.org/W2350114608', 'https://openalex.org/W2350016180', 'https://openalex.org/W2151723095', 'https://openalex.org/W2098554428', 'https://openalex.org/W2080430954', 'https://openalex.org/W2077728492', 'https://openalex.org/W2072933160', 'https://openalex.org/W2051566952', 'https://openalex.org/W2040289964', 'https://openalex.org/W2027514622', 'https://openalex.org/W2012922023', 'https://openalex.org/W2004431239', 'https://openalex.org/W1987062748', 'https://openalex.org/W1983444952', 'https://openalex.org/W1970955548', 'https://openalex.org/W1621583210', 'https://openalex.org/W141627170'], 'abstract_inverted_index': {'Platelet-derived': [0], 'growth': [1], 'factor(PDGF)and': [2], 'its': [3], 'receptors(PDGFR)play': [4], 'crucial': [5], 'role': [6], 'in': [7], 'devel-': [8], 'opment': [9], 'and': [10, 32], 'progression': [11], 'of': [12, 20, 23, 47], 'tumor,and': [13], 'are': [14], 'becoming': [15], 'hot': [16], 'targets': [17], 'for': [18], 'research': [19], 'anti-cancer': [21], 'therapy.Blockade': [22], 'PDGF/PDGFR': [24], 'signal': [25], 'transduction': [26], 'pathway': [27], 'can': [28], 'provide': [29], 'a': [30], 'potential': [31], 'strategic': [33], 'approach': [34], 'to': [35], 'antitumor': [36], 'therapy.': [37], 'In': [38], 'this': [39], 'review,we': [40], 'give': [41], 'an': [42], 'overview': [43], 'about': [44], 'clinical': [45], 'development': [46], 'pharmaceutical': [48], 'chemical': [49], 'compounds': [50], 'targeted': [51], 'PDGFR.': [52]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2380964687', 'counts_by_year': [], 'updated_date': '2024-12-15T15:51:22.498433', 'created_date': '2016-06-24'}